Tracer library / [125I]FC-131
[125I]FC-131
Also written as [125I]FC-131; [I-125]FC-131
- Radionuclide
- I-125 t½ 85493 min
- Modality
- —
- Production route
- —
- Stage
- Preclinical
- Syntheses indexed
- 0
What it is
- Compound class
- Cyclic pentapeptide (CXCR4-targeting, FC-131 scaffold)
- Target / mechanism
- CXCR4 PMID 37597009
- Clinical application
- —
- Theranostic pair
- —
Published syntheses
No synthesis has been parsed for this agent yet.
Need this precursor?We can point you to suppliers for [125I]FC-131, or handle the enquiry for you.
Get in touchQuality control Preliminary - inferred from compound class
- Ph. Eur. monograph
- not verified No Ph. Eur. check is recorded for this entry.
- USP monograph
- not verified No USP check is recorded for this entry.
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [125I]FC-131.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with I-125. | Stage 30 (2026-09-18): Modality was 'Preclinical (I-125)' -- a stage and an isotope, not a modality. Left empty: the sources use [125I]FC-131 only as the radioligand of in-vitro competitive binding assays (PMID 32724470: 'using [125I]FC-131 and [125I]CPCR4.3 as radioligands'; PMID 29527563: 'competitive binding assays employing [125I]FC131 as the radioligand'); no imaging or therapy use is stated. Stage set to Preclinical (both papers are preclinical studies).